We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-27.8%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$633M
AUM Growth
-$252M
Cap. Flow
+$52.8M
Cap. Flow %
8.34%
Top 10 Hldgs %
43.52%
Holding
70
New
22
Increased
9
Reduced
17
Closed
18

Top Buys

Rank Stock Value
1
PCG icon
PG&E
PCG
+$40.8M
2
CNC icon
Centene
CNC
+$37.3M
3
CVS icon
CVS Health
CVS
+$36.5M
4
TLND
Talend S.A. American Depositary Shares
TLND
+$34.6M
5
VICI icon
VICI Properties
VICI
+$30.8M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$45.3M
2
MO icon
Altria Group
MO
+$44.7M
3
DELL icon
Dell
DELL
+$43.7M
4
AVYA
Avaya Holdings Corp. Common Stock
AVYA
+$37.7M
5
REGI
Renewable Energy Group, Inc.
REGI
+$35.1M

Sector Composition

Rank Sector Weight
1 Healthcare 36.99%
2 Technology 22.1%
3 Energy 6.04%
4 Real Estate 5.82%
5 Communication Services 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
1
Centene
CNC
$32.5B
$36.5M 5.76%
+614,242
New +$37.3M
CVS icon
2
CVS Health
CVS
$122B
$32.4M 5.12%
+546,500
New +$36.5M
MIC
3
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$31.1M 4.91%
1,232,088
+432,088
+54% +$16.5M
MX icon
4
Magnachip Semiconductor
MX
$145M
$27.8M 4.38%
2,512,588
+141,487
+6% +$1.72M
PCG icon
5
PG&E
PCG
$38.5B
$27.6M 4.36%
+3,070,000
New +$40.8M
CHNG
6
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$25.9M 4.1%
2,597,027
+1,956,727
+306% +$27.4M
CHRS icon
7
Coherus Oncology
CHRS
$196M
$25.7M 4.06%
1,583,061
-543,019
-26% -$10M
TLND
8
DELISTED
Talend S.A. American Depositary Shares
TLND
$23M 3.63%
+1,024,196
New +$34.6M
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$22.9M 3.62%
+255,000
New +$25M
QNST icon
10
QuinStreet
QNST
$1.21B
$22.7M 3.58%
2,816,604
+505,294
+22% +$6.23M
VICI icon
11
VICI Properties
VICI
$29.4B
$21.9M 3.46%
+1,317,665
New +$30.8M
IDCC icon
12
InterDigital
IDCC
$8.89B
$21.3M 3.36%
+476,956
New +$25.1M
WSC icon
13
WillScot Mobile Mini Holdings
WSC
$4.41B
$21M 3.31%
2,070,554
-605,446
-23% -$9.83M
TBPH icon
14
Theravance Biopharma
TBPH
$877M
$20.2M 3.19%
873,577
+700,177
+404% +$17.5M
COLL icon
15
Collegium Pharmaceutical
COLL
$956M
$19.8M 3.13%
+1,213,412
New +$25M
STML
16
DELISTED
Stemline Therapeutics, Inc.
STML
$16.2M 2.56%
3,347,141
-152,859
-4% -$991K
RDUS
17
DELISTED
Radius Health, Inc.
RDUS
$16M 2.52%
1,227,929
-172,071
-12% -$3.07M
MGP
18
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$14.9M 2.36%
+630,307
New +$17.9M
BGC icon
19
BGC Group
BGC
$4.89B
$14.6M 2.3%
5,778,191
-1,116,675
-16% -$5.46M
BDSI
20
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$14.3M 2.26%
3,782,346
+1,192,058
+46% +$5.86M
SAIC icon
21
Saic
SAIC
$5.35B
$12.8M 2.03%
172,129
+115,156
+202% +$9.61M
INSM icon
22
Insmed
INSM
$28.6B
$11M 1.73%
+684,888
New +$16.2M
GPRE icon
23
Green Plains
GPRE
$1.03B
$10.4M 1.64%
2,142,750
-192,250
-8% -$2.07M
TXMD icon
24
TherapeuticsMD
TXMD
$24M
$10.2M 1.61%
192,237
-28,027
-13% -$2.78M
BMY.RT
25
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$10M 1.58%
2,635,194
+20,777
+0.8% +$68.4K
1
2 3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2020 Portfolio in Review

As of Q1 2020, Rubric Capital Management (New York) held 70 positions worth $633M, down 28% from $885M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rubric Capital Management (New York) deployed $52.8M of net new capital in Q1 2020, opening 22 new positions and adding to 9 existing holdings. Its largest new stake was PG&E: 3,070,000 shares worth $27.6M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 19% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Coherus Oncology, an estimated $10M trimmed.

  • Rubric Capital Management (New York)'s largest Q1 2020 buy was PG&E: 3,070,000 shares worth $27.6M.
  • Rubric Capital Management (New York) added most to Change Healthcare Inc. Common Stock in Q1 2020, an estimated $27.4M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2020 reduction was Coherus Oncology, cutting an estimated $10M.
  • Rubric Capital Management (New York) fully exited DuPont de Nemours in Q1 2020, selling an estimated $45.3M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 44% of its $633M portfolio in Q1 2020.
  • Rubric Capital Management (New York) opened 22 new positions and closed 18 in Q1 2020.
  • Rubric Capital Management (New York)'s portfolio value fell 28% quarter-over-quarter to $633M.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2020, filed 14 May 2020.